BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21515302)

  • 1. Comparative gene expression profiles induced by PPARγ and PPARα/γ agonists in rat hepatocytes.
    Rogue A; Renaud MP; Claude N; Guillouzo A; Spire C
    Toxicol Appl Pharmacol; 2011 Jul; 254(1):18-31. PubMed ID: 21515302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative gene expression profiles induced by PPARγ and PPARα/γ agonists in human hepatocytes.
    Rogue A; Lambert C; Jossé R; Antherieu S; Spire C; Claude N; Guillouzo A
    PLoS One; 2011 Apr; 6(4):e18816. PubMed ID: 21533120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Underlying mechanisms of pharmacology and toxicity of a novel PPAR agonist revealed using rodent and canine hepatocytes.
    Guo Y; Jolly RA; Halstead BW; Baker TK; Stutz JP; Huffman M; Calley JN; West A; Gao H; Searfoss GH; Li S; Irizarry AR; Qian HR; Stevens JL; Ryan TP
    Toxicol Sci; 2007 Apr; 96(2):294-309. PubMed ID: 17255113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome.
    Fiévet C; Fruchart JC; Staels B
    Curr Opin Pharmacol; 2006 Dec; 6(6):606-14. PubMed ID: 16973418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tesaglitazar, a PPARalpha/gamma agonist, induces interstitial mesenchymal cell DNA synthesis and fibrosarcomas in subcutaneous tissues in rats.
    Hellmold H; Zhang H; Andersson U; Blomgren B; Holland T; Berg AL; Elebring M; Sjögren N; Bamberg K; Dahl B; Westerberg R; Dillner B; Tugwood J; Tugwood J; Roberts R; Lundholm E; Camejo G; Skånberg I; Evans J
    Toxicol Sci; 2007 Jul; 98(1):63-74. PubMed ID: 17468185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood glucose-lowering nuclear receptor agonists only partially normalize hepatic gene expression in db/db mice.
    Loffler M; Bilban M; Reimers M; Waldhäusl W; Stulnig TM
    J Pharmacol Exp Ther; 2006 Feb; 316(2):797-804. PubMed ID: 16260581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.
    Cha DR; Zhang X; Zhang Y; Wu J; Su D; Han JY; Fang X; Yu B; Breyer MD; Guan Y
    Diabetes; 2007 Aug; 56(8):2036-45. PubMed ID: 17536062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and gene expression studies implicate renin and endothelin-1 in edema caused by peroxisome proliferator-activated receptor gamma agonists.
    Geese WJ; Achanzar W; Rubin C; Hariharan N; Cheng P; Tomlinson L; Ordway N; Dracopoli NC; Delmonte T; Hui L; Krishnan B; Cosma G; Ranade K
    Pharmacogenet Genomics; 2008 Oct; 18(10):903-10. PubMed ID: 18794727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists.
    Guo L; Fang H; Collins J; Fan XH; Dial S; Wong A; Mehta K; Blann E; Shi L; Tong W; Dragan YP
    BMC Bioinformatics; 2006 Sep; 7 Suppl 2(Suppl 2):S18. PubMed ID: 17118139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative transcriptional network modeling of three PPAR-α/γ co-agonists reveals distinct metabolic gene signatures in primary human hepatocytes.
    Deehan R; Maerz-Weiss P; Catlett NL; Steiner G; Wong B; Wright MB; Blander G; Elliston KO; Ladd W; Bobadilla M; Mizrahi J; Haefliger C; Edgar A
    PLoS One; 2012; 7(4):e35012. PubMed ID: 22514701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C333H, a novel PPARalpha/gamma dual agonist, has beneficial effects on insulin resistance and lipid metabolism.
    Xu C; Wang LL; Liu HY; Zhou XB; Cao YL; Li S
    Acta Pharmacol Sin; 2006 Feb; 27(2):223-8. PubMed ID: 16412273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of contraction and PPAR agonists on the expression of fatty acid transporters in rat skeletal muscle.
    Benton CR; Koonen DP; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Heikkila JJ; Bonen A
    J Physiol; 2006 May; 573(Pt 1):199-210. PubMed ID: 16484294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting glitazars: thiophene substituted oxazole containing α-ethoxy phenylpropanoic acid derivatives as highly potent PPARα/γ dual agonists devoid of adverse effects in rodents.
    Raval P; Jain M; Goswami A; Basu S; Gite A; Godha A; Pingali H; Raval S; Giri S; Suthar D; Shah M; Patel P
    Bioorg Med Chem Lett; 2011 May; 21(10):3103-9. PubMed ID: 21450468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression analysis of troglitazone reveals its impact on multiple pathways in cell culture: a case for in vitro platforms combined with gene expression analysis for early (idiosyncratic) toxicity screening.
    Vansant G; Pezzoli P; Saiz R; Birch A; Duffy C; Ferre F; Monforte J
    Int J Toxicol; 2006; 25(2):85-94. PubMed ID: 16597547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Glitazars Paradox: Cardiotoxicity of the Metabolically Beneficial Dual PPARα and PPARγ Activation.
    Kalliora C; Drosatos K
    J Cardiovasc Pharmacol; 2020 Nov; 76(5):514-526. PubMed ID: 33165133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine acidification has no effect on peroxisome proliferator-activated receptor (PPAR) signaling or epidermal growth factor (EGF) expression in rat urinary bladder urothelium.
    Achanzar WE; Moyer CF; Marthaler LT; Gullo R; Chen SJ; French MH; Watson LM; Rhodes JW; Kozlosky JC; White MR; Foster WR; Burgun JJ; Car BD; Cosma GN; Dominick MA
    Toxicol Appl Pharmacol; 2007 Sep; 223(3):246-56. PubMed ID: 17663016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver.
    Cariello NF; Romach EH; Colton HM; Ni H; Yoon L; Falls JG; Casey W; Creech D; Anderson SP; Benavides GR; Hoivik DJ; Brown R; Miller RT
    Toxicol Sci; 2005 Nov; 88(1):250-64. PubMed ID: 16081524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARalpha and PPARgamma are co-expressed, functional and show positive interactions in the rat urinary bladder urothelium.
    Egerod FL; Brünner N; Svendsen JE; Oleksiewicz MB
    J Appl Toxicol; 2010 Mar; 30(2):151-62. PubMed ID: 19757489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical mechanism of insulin sensitization, lipid modulation and anti-atherogenic potential of PPAR alpha/gamma dual agonist: Ragaglitazar.
    Sharma S; Sowjanya A; Kumari M; Suryaprakash R; Cynthia G; Suresh J; Chakrabarti R
    Life Sci; 2006 Dec; 80(3):235-44. PubMed ID: 17014868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPAR Agonists: I. Role of Receptor Subunits in Alcohol Consumption in Male and Female Mice.
    Blednov YA; Black M; Benavidez JM; Stamatakis EE; Harris RA
    Alcohol Clin Exp Res; 2016 Mar; 40(3):553-62. PubMed ID: 26857685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.